Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151744 | PMC |
| http://dx.doi.org/10.1038/s41433-021-01629-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Response to: The Dark Side of 3D Simulation in Breast Augmentation: How to Use Its Advantages and Avoid Its Drawbacks.
Aesthet Surg J
January 2025
Department of Plastic, Reconstructive, and Aesthetic Surgery, Atlas University, Istanbul, Türkiye.
Response to Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.
Haematologica
January 2025
Clinical Hematology, Nantes University Hospital, Nantes.
Not available.
View Article and Find Full Text PDFComment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies.
Haematologica
January 2025
Department of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University, Shenzhen, 518111.
Not available.
View Article and Find Full Text PDFMultidisciplinary perspectives on cumulative impact assessment for vulnerable communities: expert elicitation using a Delphi method.
Integr Environ Assess Manag
January 2025
ToxStrategies LLC, Asheville, NC, United States.
Prompted by a series of executive orders, the U.S. Environmental Protection Agency (USEPA) is promoting cumulative impact assessment (CIA) to integrate numerous factors that have the potential to impact community health, which include nonchemical stressors such as socioeconomic conditions, pre-existing health conditions, and many others that historically have not been addressed by USEPA's chemical risk assessment paradigm.
View Article and Find Full Text PDFPembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients.
Breast Cancer
January 2025
Tepe Prime, MKA Breast Cancer Clinic, 06800, Ankara, Turkey.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!